Topics: “Bisphosphonates for Osteoporosis (Therapeutics letter #83)”

Date: Tuesday, February 28, 2012
Time: 0800 to 0900 Hours
Place: ICU Conf Rm #2

Learning Objectives

1. Distinguish between evidence for bisphosphonates in primary versus secondary prevention of osteoporosis
2. Quantify the effect of bisphosphonates in osteoporosis based on evidence from a critical appraisal of randomized controlled trials
3. Understand the implications of the bias within the aforementioned trials

Presented by:     Aaron M Tejani, Therapeutics Initiative (UBC)

Accreditation:
“This event is an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
"This educational session has been approved for One (1) MAINPRO-MI Credit by the College of Family Physicians of Canada.

*******Coffee will be provided*******